WallStreetZenWallStreetZen

NASDAQ: ANIP
Ani Pharmaceuticals Inc Stock Ownership - Who owns Ani Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ani Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nikhil LalwaniPRESIDENT CEO2024-11-2630,000$29.00
$870.00kBuy
Nikhil LalwaniPRESIDENT CEO2024-11-263,481$58.30
$202.94kSell
Nikhil LalwaniPRESIDENT CEO2024-11-2630,000$57.95
$1.74MSell
Christopher MutzHEAD OF RARE DISEASE2024-11-156,500$57.70
$375.05kSell
Thomas Andrew RowlandSVP HEAD - ESTABLISHED BRANDS2024-11-15867$56.58
$49.05kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2024-11-13250$61.36
$15.34kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2024-10-14250$57.19
$14.30kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2024-09-13250$56.82
$14.21kSell
Krista DavisSVP CHIEF HR OFFICER2024-09-121,486$56.15
$83.44kSell
Nikhil LalwaniPRESIDENT CEO2024-09-083,646$60.51
$220.62kSell

1 of 9

ANIP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIP insiders and whales buy or sell their stock.

ANIP Shareholders

What type of owners hold Ani Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Meridian Venture Partners II LP89.11%18,737,728$1.07BInsider
Robert E. Brown Jr.80.69%16,967,490$964.77MInsider
Ross J. Mangano27.54%5,792,084$329.34MInsider
Blackrock Inc 112.79%2,689,712$152.94MInstitution
Tracy Marshbanks10.98%2,308,568$131.27MInsider
Vanguard Group Inc6.41%1,348,111$76.65MInstitution
Victor A. Morgenstern4.45%936,014$53.22MInsider
Goldman Sachs Group Inc3.41%716,069$40.72MInstitution
Muthusamy Shanmugam3.38%711,272$40.44MInsider
State Street Corp3.35%703,843$40.02MInstitution

1 of 3

ANIP vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIP28.20%71.80%Net SellingNet Selling
TLRY10.12%1.97%Net BuyingNet Buying
HROW28.90%71.10%Net BuyingNet Buying
COLL58.10%41.90%Net SellingNet Selling
AVDL77.26%13.51%Net Selling
View Top Pharmaceutical Stocks

Ani Pharmaceuticals Stock Ownership FAQ

Who owns Ani Pharmaceuticals?

Ani Pharmaceuticals (NASDAQ: ANIP) is owned by 89.90% institutional shareholders, 228.92% Ani Pharmaceuticals insiders, and 0.00% retail investors. Meridian Venture Partners II LP is the largest individual Ani Pharmaceuticals shareholder, owning 18.74M shares representing 89.11% of the company. Meridian Venture Partners II LP's Ani Pharmaceuticals shares are currently valued at $1.05B.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.